Stock image

April 29, 2009 – The FDA cleared of a new generation of patient positioning system (PPS) developed by Ion Beam Applications S.A. (IBA) and ProCure Treatment Centers Inc. (ProCure), which is designed to improve proton therapy.

The basic configuration of the robotic PPS is a Selective Compliant Assembly Robot Arm (SCARA). It combines commercially available robotic sub-systems, which makes it cost-effective and easy to maintain, with custom designed arms to allow for the specific needs of patient positioning in proton therapy. A unique dual coupler system is attached at the end of the wrist of the robot arm that is used to attach different devices to the PPS, such as a patient table or chair, or a test phantom. The device employs reportedly safe robotic technology that meets the standards of the Robotics Industry Association (RIA).

Some specific design elements of the PPS compared to earlier generations include:

- An increase of the clinically usable area of the proton therapy treatment room. This larger work envelope also makes it suitable for image-guided proton therapy in combination with 3D imaging capability in the treatment room.

- Optimized movement speeds designed for safe and precise motion of the PPS. The range of speed and motion with the pitch-and-roll axes of the robot is restricted to reduce the sensation of movement when the patient is on the table.

- The ergonomics are said to be better, as there are no moving parts in the floor system that supports the device, which allows greater accessibility to the treatment area for patients and therapists

The new PPS is part of ProCure’s strategy to make proton therapy better and more accessible. This includes making the therapy more cost effective and creating a platform that will allow easy integration of future advanced image-guided proton treatments.

The first clinical installation will be at the ProCure Proton Therapy Center in Oklahoma City, scheduled to open this summer.

For more information: www.procure.com

 


Related Content

News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Treatment Planning

February 2, 2024 — RaySearch Laboratories announced that the number of radiotherapy centers that have chosen RayStation ...

Time February 02, 2024
arrow
Feature | Radiation Oncology | By Melinda Taschetta-Millane

Over the past several years, technological advancements have driven the development of more precise and targeted ...

Time January 16, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

January 11, 2024 — On January 9th, 2024, a scientific prototype for MRI-guided proton therapy was inaugurated in Dresden ...

Time January 11, 2024
arrow
News | Radiation Therapy

December 27, 2023 — Nationwide Children’s Hospital and The Ohio State University Comprehensive Cancer Center – Arthur G ...

Time December 27, 2023
arrow
Feature | Proton Therapy | By Christine Book

A University of Miami Radiation Oncology department summary noted: “In radiation oncology, the art of patient care meets ...

Time October 11, 2023
arrow
Videos | Proton Therapy

Tune in to ITN’s latest “One on One” video series with Michael Butkus, PhD, for insights into proton therapy ...

Time October 10, 2023
arrow
News | Proton Therapy

October 4, 2023 — RaySearch Laboratories AB has announced its expanded collaboration with P-Cure, aiming at enhancing ...

Time October 04, 2023
arrow
Feature | ASTRO | By Christine Book

September 26, 2023 — Ahead of the 65th American Society for Radiation Oncology Annual Meeting, ASTRO 2023, ITN’s ...

Time September 26, 2023
arrow
Feature | Proton Therapy | By Christine Book

An overview of significant developments in proton therapy, over just the past six months, reinforces the pace of ...

Time September 21, 2023
arrow
Subscribe Now